LXEO
Lexeo Therapeutics, Inc.
3.20$
-3.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 7.8% | 949.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 92.2% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| 11,860.2% | 33,154.1% | 2,893.0% | – | – | – | – | – | – | – | – | 944.8% | – | – | – | – | – | – | – | |
| – | 8,327.0% | 499.2% | – | – | – | – | – | – | – | – | 463.8% | – | – | – | – | – | – | – | |
| 14,726.0% | 41,481.1% | 3,392.3% | – | – | – | – | – | – | – | – | 1,408.5% | – | – | – | – | – | – | – | |
| -14,633.9% | -41,381.1% | -3,292.3% | – | – | – | – | – | – | – | – | -1,408.5% | – | – | – | – | – | – | – | |
| – | 24.3% | 5.5% | – | – | – | – | – | – | – | – | 1.5% | – | – | – | – | – | – | – | |
| -14,613.5% | -40,927.0% | -3,211.9% | – | – | – | – | – | – | – | – | -1,333.5% | – | – | – | – | – | – | – | |
| 0.0% | -471.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -14,613.5% | -40,927.0% | -3,211.9% | – | – | – | – | – | – | – | – | -1,333.5% | – | – | – | – | – | – | – | |
| -14,626.0% | -39,953.2% | -3,142.0% | – | – | – | – | – | – | – | – | -1,305.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.